Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Gupshup Acquires Active.Ai, the Leading Conversational AI Platform for Banks and Fintech Companies
Acquisition Brings Advanced, AI powered Omnichannel Conversational Engagement Solutions to BFSI Organizations SAN FRANCISCO &…
PT Freeport Indonesia Announces Senior Notes Offering
JAKARTA, Indonesia–(BUSINESS WIRE)–PT Freeport Indonesia (“PT-FI” or the “Company”) announced today that it intends to…
Hitachi Energy Launches OceaniQ – Innovative Solutions for the Offshore Environment
ZURICH, SWITZERLAND, Apr 5, 2022 – (JCN Newswire) – Hitachi Energy today launched its OceaniQ…
Fujitsu delivers new technology to Japan Aerospace Exploration Agency for mapping and analyzing space debris
TOKYO, Apr 5, 2022 – (JCN Newswire) – Fujitsu today announced the development and deployment…
DOCOMO Launches Carbon-neutrality Website to Encourage Climate Action
TOKYO, Apr 5, 2022 – (JCN Newswire) – NTT DOCOMO, INC. announced today that it…
Airtel and Mavenir Conduct India’s First Open RAN Based 5G NSA Validation
Speeds of over 1 Gbps in 5G Non-Standalone configuration validating the growing maturity of Open…
Sanara MedTech Inc. Announces Closing of Merger to Acquire Precision Healing Inc.
FORT WORTH, TX, April 04, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,”…
Asia’s HR Community to Reunite at HR Tech Festival Asia 2022 Both In-person and Virtually to Refresh and Reimagine the Future of Workforce Management
Singapore, Apr 5, 2022 – (ACN Newswire) – 2022 continues to be a challenging year…
Labaton Sucharow LLP Files Securities Class Action Lawsuit Against Everbridge, Inc.
NEW YORK–(BUSINESS WIRE)–Labaton Sucharow LLP (“Labaton Sucharow”) announces that on April 4, 2022, it filed…
Drones Are the New First Responders
By Dr. Shaun Passley In terms of sheer versatility, it’s hard to imagine an invention…
Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance
Annual Report on Form 10-K for fiscal year ended December 31, 2021 to be filed…
AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today…
New Data at AAN 2022 Highlight Real-World Evidence from Biogen’s MS Portfolio and Emerging Research on Disease Progression
Data from NOVA study further support the efficacy and safety of natalizumab IV when administered…
Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital
WALTHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
Terns Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
FOSTER CITY, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-710, an A101 AAV Vector-based, Aerosol-delivered Genetic Medicine for the Treatment of Cystic Fibrosis
EMERYVILLE, Calif., April 04, 2022 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (4DMT) (Nasdaq: FDMT),…
Nurix Therapeutics Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage…
Kala Pharmaceuticals to Present Phase 1b Clinical Data for KPI-012 in Patients with PCED at 2022 ARVO Annual Meeting
ARLINGTON, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…